Results 1 to 10 of about 6,403 (197)

Paracoccidioidomycosis with sarcoid-like cutaneous lesion: A clinicopathological challenge

open access: yesIDCases, 2022
We describe a case of sarcoid-like cutaneous paracoccidioidomycosis in a 26-year-old male, with a 10-year evolution, wrongly diagnosed as granulomatous rosacea. The correct diagnosis was only possible after the appearance of a new skin lesion with a more
Cristiane Botelho Miranda Cárcano   +4 more
doaj   +2 more sources

Factors influencing treatment adherence in paracoccidioidomycosis in Brazil

open access: yesPublic Health Challenges, 2023
Introduction Paracoccidioidomycosis is a systemic mycosis endemic to Latin America, with frequent reports of poor treatment adherence resulting in worse clinical outcomes.
Wdson Luis Lima Kruschewsky   +7 more
doaj   +2 more sources

EPIDEMIOLOGY OF PARACOCCIDIOIDOMYCOSIS [PDF]

open access: yesRevista do Instituto de Medicina Tropical de São Paulo, 2015
SUMMARYThe epidemiological characteristics of paracoccidioidomycosis were reviewed and updated. The new endemic areas in Brazil were discussed in the section regarding the geographic distribution of the mycosis.
Roberto MARTINEZ
doaj   +4 more sources

Paracoccidioidomycosis [PDF]

open access: yesRevista do Instituto de Medicina Tropical de São Paulo, 1994
Marcello FRANCO   +3 more
doaj   +9 more sources

Paracoccidioidomycosis: epidemiological, clinical, diagnostic and treatment up-dating [PDF]

open access: yesAnais Brasileiros de Dermatologia, 2013
Paracoccidioidomycosis is an acute - to chronic systemic mycosis caused by fungi of the genus Paracoccidioides. Due to its frequent tegument clinical expression, paracoccidioidomycosis is an important disease for dermatologists, who must be up-to-date ...
Silvio Alencar Marques
doaj   +1 more source

Chorioretinal paracoccidioidomycosis treated with intravitreal voriconazole and therapeutic vitrectomy

open access: yesAmerican Journal of Ophthalmology Case Reports, 2021
Purpose: To report a case of aggressive chorioretinal paracoccidioidomycosis requiring treatment with systemic antifungal agents, frequent intravitreal voriconazole injections, and surgical excision.
Isdin Oke   +4 more
doaj   +1 more source

Canine paracoccidioidomycosis [PDF]

open access: yesMedical Mycology, 2004
Paracoccidioidomycosis (PCM) is a severe disease caused by the dimorphic fungus Paracoccidioides brasiliensis, which is characterized by granulomatous pulmonary and systemic lesions, affecting mainly men between 20 and 60 years of age. Reports of PCM disease in animals are rare, but the disease has been described in armadillos.
G, Ricci   +5 more
openaire   +2 more sources

Paracoccidioidomycosis vaccine [PDF]

open access: yesHuman Vaccines & Immunotherapeutics, 2012
Paracoccidioidomycosis is a granulomatous pulmonary infection that is generally controlled by chemotherapy. The efficacy of treatment, however, is limited by the status of the host immune response. The inhibition of a Th-2 immunity or the stimulation of Th-1 cytokines generally increases the efficacy of antifungal drugs.
Travassos, Luiz Rodolpho UNIFESP   +1 more
openaire   +3 more sources

Paracoccidioidomycosis with digestive manifestations in a pediatric patient

open access: yesBoletín Médico del Hospital Infantil de México, 2022
Background: Paracoccidioidomycosis is a systemic infection caused by the fungus Paracoccidioides. It may present in two forms: an acute/subacute form, whose most frequent manifestations include weight loss, fever, anemia, and adenopathy, and a chronic ...
Alexis J. Ormeño-Julca   +4 more
doaj   +1 more source

Mid-line destructive syndrome secondary to infectionby paracoccidioides sp. A case report

open access: yesIatreia, 2022
Midline destructive disease is a group of severe and destructive inflammatory and tumor diseases of the midface area, among which paracoccidioidomycosis is one of the main etiologies in tropical countries.
Barrera-Escobar, Sebastián   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy